NO970514L - Bakteriell produksjon av hydrofobiske polypeptider - Google Patents

Bakteriell produksjon av hydrofobiske polypeptider

Info

Publication number
NO970514L
NO970514L NO970514A NO970514A NO970514L NO 970514 L NO970514 L NO 970514L NO 970514 A NO970514 A NO 970514A NO 970514 A NO970514 A NO 970514A NO 970514 L NO970514 L NO 970514L
Authority
NO
Norway
Prior art keywords
bacterial production
production
hydrophobic polypeptides
cation concentration
polypeptides
Prior art date
Application number
NO970514A
Other languages
English (en)
Other versions
NO970514D0 (no
NO324529B1 (no
Inventor
Glenn Dorin
Patrick J Mcalary
Kathleen M Wong
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of NO970514D0 publication Critical patent/NO970514D0/no
Publication of NO970514L publication Critical patent/NO970514L/no
Publication of NO324529B1 publication Critical patent/NO324529B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19970514A 1995-06-06 1997-02-05 Fremgangsmate for a fremstille interferon-beta i en Escherischia coli-vertscelle. NO324529B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/477,310 US5814485A (en) 1995-06-06 1995-06-06 Production of interferon-β (IFN-β) in E. coli
PCT/US1996/009155 WO1996039523A2 (en) 1995-06-06 1996-06-05 Bacterial production of hydrophobic polypeptides

Publications (3)

Publication Number Publication Date
NO970514D0 NO970514D0 (no) 1997-02-05
NO970514L true NO970514L (no) 1997-03-17
NO324529B1 NO324529B1 (no) 2007-11-12

Family

ID=23895395

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970514A NO324529B1 (no) 1995-06-06 1997-02-05 Fremgangsmate for a fremstille interferon-beta i en Escherischia coli-vertscelle.

Country Status (17)

Country Link
US (1) US5814485A (no)
EP (1) EP0778893B1 (no)
JP (3) JP4131554B2 (no)
AT (1) ATE449175T1 (no)
AU (1) AU6154996A (no)
BR (1) BR9606491A (no)
CA (1) CA2195799C (no)
DE (1) DE69638077D1 (no)
FI (1) FI970445A (no)
IL (1) IL120009A0 (no)
IN (1) IN190514B (no)
MX (1) MX9700818A (no)
MY (1) MY118492A (no)
NO (1) NO324529B1 (no)
NZ (1) NZ310710A (no)
TW (1) TW494138B (no)
WO (1) WO1996039523A2 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6399996A (en) * 1996-06-19 1998-01-07 Chiron Corporation Bacterial production of interferon-beta using low levels of sodium and potassium ions
US6514729B1 (en) 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
US7544354B2 (en) * 2000-10-27 2009-06-09 Novartis Vaccines And Diagnostics Methods of protein purification and recovery
EP1414866A2 (en) * 2000-11-21 2004-05-06 The Texas A & M University System Fgf-affinity chromatography
AU2002222557A1 (en) * 2000-11-29 2002-06-11 Morinaga Milk Industry Co., Ltd. Interferon therapeutic effect-potentiating agents
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
RU2006104023A (ru) * 2003-07-11 2006-07-27 Шеринг Акциенгезельшафт (De) УЛУЧШЕННЫЕ РЕКОМБИНАНТНЫЕ ПОЛИПЕПТИДЫ ЧЕЛОВЕЧЕСКОГО ИНТЕРФЕРОНА -БЕТА-1b
EP1691825B1 (en) * 2003-12-11 2011-09-28 Ares Trading S.A. Stabilized interferon liquid formulations
JP4889505B2 (ja) 2004-02-02 2012-03-07 アンブレツクス・インコーポレイテツド 被修飾されたヒト成長ホルモンポリペプチドおよびこれらの使用
WO2009100255A2 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses
DOP2006000117A (es) * 2005-05-19 2007-11-30 Schering Ag Terapia génica de interferon-beta usando un sistema mejorado de expresión regulada
US20070179113A1 (en) * 2005-05-19 2007-08-02 Schering Aktiengesellachaft GM-CSF gene therapy for Crohn's disease using an improved regulated expression system
EP1885858A2 (en) * 2005-05-19 2008-02-13 Bayer Schering Pharma Aktiengesellschaft Treatment of disease using an improved regulated expression system
US20080076729A1 (en) * 2005-05-19 2008-03-27 Schering Aktiengesellachaft Interferon-beta gene therapy using an improved, regulated expression system
US20080003202A1 (en) * 2006-03-28 2008-01-03 Thierry Guyon Modified interferon-beta (IFN-beta) polypeptides
EP2572734B1 (en) 2006-10-31 2016-04-06 East Carolina University Cytokine-based fusion proteins for treatment of immune disorders
WO2008125222A2 (en) * 2007-04-11 2008-10-23 Bayer Schering Pharma Aktiengesellschaft New modulation molecules for an improved regulated expression system
EP2076533B1 (en) 2007-05-02 2014-10-08 Ambrx, Inc. Modified interferon beta polypeptides and their uses
US8273561B2 (en) * 2007-10-05 2012-09-25 Nuron Biotech, Inc. High pressure treatment of aggregated interferons
DK2234645T3 (da) * 2007-12-20 2012-07-09 Merck Serono Sa Peg-interferon-beta-formuleringer
KR20090124204A (ko) * 2008-05-29 2009-12-03 (주)바이오큐어팜 아미노 말단의 메티오닌이 제거된 재조합 사람 변이인터페론-베타 단백질을 생산하는 재조합 대장균 및 이의제조방법
AU2010234743A1 (en) 2009-03-31 2011-10-20 East Carolina University Cytokines and neuroantigens for treatment of immune disorders
MX2012008893A (es) * 2010-02-01 2013-02-27 Digna Biotech Sl Procedimiento para la produccion de interferon alfa 5.
WO2011109556A2 (en) 2010-03-04 2011-09-09 Pfenex Inc. Method for producing soluble recombinant interferon protein without denaturing
RU2473696C1 (ru) * 2011-07-14 2013-01-27 Закрытое акционерное общество "ГЕНЕРИУМ" ПРОМЫШЛЕННЫЙ СПОСОБ ПОЛУЧЕНИЯ И ОЧИСТКИ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА β-1b ЧЕЛОВЕКА ИЗ ТЕЛЕЦ ВКЛЮЧЕНИЯ
JP6363326B2 (ja) * 2013-03-11 2018-07-25 株式会社コーセー 酵母・細菌共通培養方法およびこれに用いる酵母・細菌共通培養培地
JP7151049B2 (ja) * 2018-03-30 2022-10-12 三井化学株式会社 微生物を増殖させる方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499188A (en) * 1982-05-05 1985-02-12 Cetus Corporation Bacterial production of heterologous polypeptides under the control of a repressible promoter-operator
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4656132A (en) * 1984-03-28 1987-04-07 Cetus Corporation Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
JPH0755152B2 (ja) * 1986-06-02 1995-06-14 日本化薬株式会社 組換え遺伝子産物の製法及び培地

Also Published As

Publication number Publication date
FI970445A0 (fi) 1997-02-03
EP0778893B1 (en) 2009-11-18
JP4131554B2 (ja) 2008-08-13
AU6154996A (en) 1996-12-24
DE69638077D1 (de) 2009-12-31
BR9606491A (pt) 1997-09-02
JPH11501820A (ja) 1999-02-16
JP4317890B2 (ja) 2009-08-19
ATE449175T1 (de) 2009-12-15
IL120009A0 (en) 1997-04-15
WO1996039523A3 (en) 1997-01-30
FI970445A (fi) 1997-03-26
NZ310710A (en) 1999-01-28
TW494138B (en) 2002-07-11
US5814485A (en) 1998-09-29
NO970514D0 (no) 1997-02-05
JP2008086331A (ja) 2008-04-17
CA2195799A1 (en) 1996-12-12
EP0778893A2 (en) 1997-06-18
JP2008283988A (ja) 2008-11-27
IN190514B (no) 2003-08-02
MX9700818A (es) 1997-05-31
MY118492A (en) 2004-11-30
NO324529B1 (no) 2007-11-12
CA2195799C (en) 2010-02-09
WO1996039523A2 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
NO970514D0 (no) Bakteriell produksjon av hydrofobiske polypeptider
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
DE3065039D1 (en) Total enzymatic hydrolysate of lactoserum proteins, production and applications
NO900770D0 (no) Produksjon av glykoseoksidase i rekombinante systemer.
YU45871B (sh) Polipeptid sa humanim imunointerferonskim (ifn-gama) svojstvima
ES8706443A1 (es) Un procedimiento para preparar una solucion parenteral de activador de plasminogeno de tejido (t-pa)
ES529023A0 (es) Produccion de activador de plasminogeno de tejido humano, utilizando vectores que codifican proteina de dihidrofolato- reductasa.
FI864654A (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
ATE255632T1 (de) Immortalisierung bzw. desimmortalisierung von zellen
FI925988A0 (fi) Foerfarande foer framstaellning av b-laktamer
NO20052209D0 (no) Fremgansmate for fremstilling av nytt og naturlig avermektin
SE8801701D0 (sv) Production technology based on enzymic method
EP0726944A4 (en) GLYCOSYLATED AND NON-GLYCOSYLATED PROTEINS, BACTERICIDES AND INCREASING PERMEABILITY, AND PROCESS FOR PRODUCING THE SAME
FR2665168B1 (fr) Composition comportant un succinoglycane.
ATE71149T1 (de) Monoklonale antikoerper.
RU94043769A (ru) Способ повышения продукции протеина с, способ повышения уровня его модификации
ES8602114A1 (es) Procedimiento para la obtencion de la nueva enzima 1-meti- lhidantoinasa.
DE60042273D1 (de) Antitumorantikörper, proteine und deren verwendung
AU8011498A (en) Novel ppgpp synthetase and expression systems for improved production of proteinof interest
AU2099800A (en) Production of proteins
MY103822A (en) Antiulcer pyrimidine derivatives.
ES8502162A1 (es) Procedimiento para preparar un hidrolizado proteinico
ITMI910861A1 (it) Procedimento migliorato per la preparazione di polipeptidi maturi
AU3418600A (en) A (bacillus) protein production cell
GR3003950T3 (no)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees